e-learning
resources
Vienna 2003
Sunday 28.09.2003
Markers, mediators and mechanisms of human lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
H. Batura-Gabryel, A. Szczepanik (Poznan, Poland)
Source:
Annual Congress 2003 - Markers, mediators and mechanisms of human lung injury
Session:
Markers, mediators and mechanisms of human lung injury
Session type:
Thematic Poster Session
Number:
623
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Batura-Gabryel, A. Szczepanik (Poznan, Poland). Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?. Eur Respir J 2003; 22: Suppl. 45, 623
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Biochemical parameters of sputum and their correlation with inflammation blood markers in AECOPD patients
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
The lung parenchyma in COPD patients:
in vitro
mechanics and its correlation with inflammatory and structural changes
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Relationship of airway structural changes and lung function abnormalities with blood and BAL biomarkers in asthma
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD
Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients
Year: 2009
Relationships between inflammatory markers, response to therapy, and lung function decline
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017
Associations between blood eosinophils and decline in lung function among adults with and without asthma
Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017
Year: 2018
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests
Source: Eur Respir J 2002; 20: Suppl. 38, 106s
Year: 2002
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept